Systemic therapy for HER2-positive metastatic breast cancer: Current and future trends
Last Updated: Friday, July 17, 2026
With a focus on systemic therapy, this review article spotlights new strategies in development for the treatment of patients with metastatic HER2+ breast cancer, as well as the mechanisms of action and associated side effects. It also discusses treatment combinations to overcome resistance and immune approaches currently being studied.